Intervet
Launches One Dose, Modified Live Respiratory & Reproductive
Vaccine
|
|
During industry meetings last month in San Diego, Calif., Intervet
revealed the culmination of its recent product vaccine research in
Vista, a modified live respiratory and reproductive vaccine for cattle.
Vista provides long lasting protection against Infectious Bovine Rhinotracheitis
(IBR), Bovine Viral Diarrhea (BVD) Type 1 and Type 2, Bovine Respiratory
Disease Syneytial Virus (BRSV), Parainfluenza3 (PI3), with either
Pasteurella multocida/Mannheimia haemolytica or Leptospira (including
hardjo-bovis) combinations.
“Vista is really in a class by itself, providing superior extended
viral protection against the most common respiratory and reproductive
diseases that continue to pose immense economic consequences to the
beef industry,” says Jeff Baxter, Intervet Marketing Manager,
Cattle Vaccines. “The introduction of Vista provides bovine
veterinarians and beef producers an opportunity to elevate their expectations
and demand more from a respiratory and reproductive vaccine.”
Intervet Senior Technical Services Specialist Tom Shelton, DVM, says
Vista’s efficacy is supported by an unprecedented amount of
data.
“No other cattle vaccine at the time of launch has had as much
data supporting its safety and efficacy as Vista,” Shelton says.
“Vista is the only modified life vaccine with a six month duration
of immunity label for IBR and BVD Type 1 and Type 2.”
Research indicates the IBR faction in Vista provides protection from
clinical signs of IBR following an IBR challenge 182 days following
vaccination. A single dose of Vista also is proven to protect calves
for 183 days post vaccination from BVD Type 1, as well as the highly
virulent challenge strain that was responsible for the severely devastating
BVD type 2 outbreaks in 1993.
“The introduction of Vista signifies Intervet’s commitment
to the development of breakthrough products that deliver the most
complete results and the greatest return on investment for veterinarians
and beef producers.” ©
